There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Join NJ ACTS Workforce Development Core for an NIH Fellowship Grant Writing Workshop this Fall
- NJACTS Community Engagement Core COVID-19 Resources
- NJACTS Community Engagement Core Available Services
- Unveiling the Biomechanical Forces that Drive Scarring.
- Scientists Discover Class of Crystals With Properties That May Prove Revolutionary.
Categories
- Community (2,291)
- Covid (988)
- CTO Events (6)
- News (2,917)
- Pilots (21)